Literature DB >> 7035560

A new complement-dependent bactericidal factor found in nonimmune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella.

I Ihara, Y Harada, S Ihara, M Kawakami.   

Abstract

It has been shown that nonimmune mouse sera contain a complement-dependent bactericidal factor that reacts specifically with Ra chemotype Salmonella. In this study we investigate a specific determinant to which this factor binds. This factor bound to Ra chemotype lipopolysaccharide (LPS) but not to S or Re chemotype LPS. The binding was markedly inhibited by N-acetyl-D-glucosamine (GlcNAc), which was the nonreducing terminal of the Ra polysaccharide chain and by certain monosaccharides structurally relating to L-glycero-D-mannoheptose, a terminal component of a side branch of Ra polysaccharide. The factor bound to the Ra bacteria could be eluted with a medium containing GlcNAc. These results indicate that the specific determinant is the polysaccharide region of LPS characteristic of Ra chemotype Salmonella. Ca2+ but not Mg2+ was required for the specific binding of the factor to cells of Ra bacteria. A molecule composed of a polypeptide of 28,000 m.w. was found in the active fraction obtained by the monosaccharide elution. However, no polypeptides corresponding to light and heavy chains of mouse immunoglobins were detected from the active fraction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035560

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.

Authors:  Kevan L Hartshorn; Mitchell R White; Erika C Crouch
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms.

Authors:  M Devyatyarova-Johnson; I H Rees; B D Robertson; M W Turner; N J Klein; D L Jack
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 4.  Collectins, collectin receptors and the lectin pathway of complement activation.

Authors:  R Malhotra; J Lu; U Holmskov; R B Sim
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  Plasma factor triggering alternative complement pathway activation by liposomes.

Authors:  K Funato; C Yamashita; J Kamada; S Tominaga; H Kiwada
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

Review 6.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

7.  A 28,000-dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide.

Authors:  L Brade; H Brade
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.

Authors:  S W Vukajlovich
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Binding of mannan-binding protein to various bacterial pathogens of meningitis.

Authors:  L C van Emmerik; E J Kuijper; C A Fijen; J Dankert; S Thiel
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection.

Authors:  Yan Wang; Jiangwei Yan; Yuling Shi; Ping Li; Chuanxuan Liu; Qingjun Ma; Ruifu Yang; Xiaoyi Wang; Lina Zhu; Xiao Yang; Cheng Cao
Journal:  BMC Infect Dis       Date:  2009-05-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.